5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with aspartic acid in 3 studies
| Studies (5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate) | Trials (5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate) | Recent Studies (post-2010) (5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate) | Studies (aspartic acid) | Trials (aspartic acid) | Recent Studies (post-2010) (aspartic acid) |
|---|---|---|---|---|---|
| 19 | 0 | 0 | 23,005 | 417 | 4,018 |
| Protein | Taxonomy | 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate (IC50) | aspartic acid (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.638 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 90.1265 | |
| Excitatory amino acid transporter 2 | Homo sapiens (human) | 11 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 1.638 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Graham, SH; Gwinn, R; Kadota, K; Leach, MJ; Meldrum, BS; Millan, MH; Simon, RP; Swan, JH | 1 |
| Lekieffre, D; Meldrum, BS | 1 |
| Arvin, B; Chapman, AG; Le Peillet, E; Meldrum, BS; Ottersen, OP; Torp, R | 1 |
3 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and aspartic acid
| Article | Year |
|---|---|
Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87.
Topics: Animals; Aspartic Acid; Brain; Caudate Nucleus; Cerebral Arteries; Glutamates; Glutamine; In Vitro Techniques; Ischemic Attack, Transient; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Taurine; Veratrine | 1992 |
The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study.
Topics: Amino Acids; Animals; Aspartic Acid; Corpus Striatum; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Hippocampus; Ischemic Attack, Transient; Male; Microdialysis; Neurons; Prosencephalon; Pyramidal Tracts; Pyrimidines; Rats; Rats, Wistar; Taurine; Time Factors | 1993 |
Effect of ischaemia and reperfusion on the extra- and intracellular distribution of glutamate, glutamine, aspartate and GABA in the rat hippocampus, with a note on the effect of the sodium channel blocker BW1003C87.
Topics: Animals; Aspartic Acid; Calcium Channel Blockers; Extracellular Space; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glutamine; Hippocampus; Intracellular Fluid; Ischemic Attack, Transient; Male; Microdialysis; Microscopy, Immunoelectron; Neurons; Pyramidal Cells; Pyrimidines; Rats; Rats, Wistar; Reperfusion; Time Factors | 1993 |